Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aurobindo Pharma
Pharma
J&J-Yuhan, Merck, biosecurity—Fierce Pharma Asia
Yuhan's Lazcluze made history. Merck adjusted an ADC deal with Kelun. Certain U.S. lawmakers pressed the FDA to scrutinize Chinese military hospitals.
Angus Liu
Aug 23, 2024 10:05am
FDA rebukes troubled Eugia production site with a warning letter
Aug 19, 2024 8:10am
TROP2 ADCs, Merck-Daiichi, Eisai—Fierce Pharma Asia
Aug 9, 2024 8:25am
FDA hits Aurobindo's Eugia with 'Official Action Indicated' tag
Aug 6, 2024 8:50am
Eisai, Takeda, BIOSECURE Act—Fierce Pharma Asia
May 17, 2024 8:30am
Aurobindo's Eugia tallies a 5th Form 483 in less than a year
May 14, 2024 9:40am
